Leukapheresis Device Market Trends and Insights: Global Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Leukapheresis Device Market size between 2026 and 2035?
The leukapheresis device market has experienced significant growth over the past few years. This market is projected to expand from $0.7 billion in 2025 to $0.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.6%. Key drivers for historical market growth include an increase in the prevalence of leukemia and autoimmune disorders, the uptake of stem cell therapies, improvements in blood cell separation technology, more extensive clinical research activities, and the development of hospital-based apheresis services.
The leukapheresis device market is projected to experience robust expansion over the coming years. This market is anticipated to reach $1.01 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. Several factors are contributing to this growth during the forecast period, including an increased demand for portable leukapheresis systems, the incorporation of AI and automation into these devices, the ongoing expansion of biopharmaceutical research, the approval of advanced apheresis devices by regulatory bodies, and growing investments in precision medicine. Key trends expected during this period involve personalized leukapheresis treatments, the development of minimally invasive apheresis techniques, the adoption of portable and point-of-care leukapheresis devices, the integration of real-time monitoring systems, and improvements in automation and workflow efficiency.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp
Which Drivers Are Impacting Market Performance In The Leukapheresis Device Market?
The increasing occurrence of blood-related conditions is projected to boost the expansion of the leukapheresis device market in the future. These disorders involve issues affecting the form or operation of blood cells, leading to difficulties in oxygen transportation, immune system function, or coagulation. The growing frequency of blood-related illnesses is largely due to an older demographic, given that elderly people are more prone to ailments like anemia, leukemia, and other hematological conditions. Leukapheresis devices aid in addressing these conditions by precisely removing surplus or abnormal white blood cells from circulation, which helps ease symptoms and lessen complications in illnesses like leukemia and autoimmune diseases. As an illustration, in March 2024, the Leukaemia Foundation, a non-profit organization based in Australia, reported that approximately 19,500 Australians received a diagnosis of blood cancer, encompassing leukemia, lymphoma, and myeloma. Of these, nearly 43% incurred substantial out-of-pocket treatment expenses, and 42% took more than three months away from work, underscoring both the increasing occurrence and the financial strain on patients and their relatives relative to prior years. Consequently, the increasing occurrence of blood-related disorders is fueling the expansion of the leukapheresis device market.
Which Segments Are Contributing To The Growth Of The Leukapheresis Device Market?
The leukapheresis device market covered in this report is segmented –
1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices
2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters
3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers
Subsegments:
1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices
2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems
3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems
4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices
5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators
6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags
7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems
Which Trends Are Influencing The Performance And Direction Of The Leukapheresis Device Market?
Major enterprises operating within the leukapheresis device market are increasingly focused on investing in regional manufacturing capabilities. This strategy aims to enhance local access to high-quality therapeutic devices and support national healthcare goals. Such regional manufacturing investments contribute to the creation of efficient and flexible supply chains, which in turn ensure timely delivery, reduce dependency on imports, and improve the affordability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, collaborated with Terumo Medical Products (Hangzhou) Co., Ltd., a China-based medical technology subsidiary, to initiate localized production in Hangzhou, China. This strategic move involves the domestic manufacturing of key leukapheresis products, including the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both of which are widely utilized in China for therapeutic apheresis, stem cell collection, and blood component separation.
Who Are The Prominent Global Companies Shaping The Leukapheresis Device Market Landscape?
Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report
Which Region Currently Holds The Largest Share Of The Leukapheresis Device Market?
North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Leukapheresis Device Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp
Browse Through More Reports Similar to the Global Leukapheresis Device Market 2026, By The Business Research Company
Interventional Oncology Devices Global Market Report 2026
Nephrostomy Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/nephrostomy-devices-global-market-report
Electrical Stimulation Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
